Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals | Zendy

Daniel J. Boffa | Zendy; Katherine Mallin | Zendy; Jeph Herrin | Zendy; Benjamin J. Resio | Zendy; Michelle C. Salazar | Zendy; Bryan E. Palis | Zendy; Matthew A. Facktor | Zendy; Ryan McCabe | Zendy; Heidi Nelson | Zendy; Lawrence N. Shulman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals

Author(s) -

Daniel J. Boffa,

Katherine Mallin,

Jeph Herrin,

Benjamin J. Resio,

Michelle C. Salazar,

Bryan E. Palis,

Matthew A. Facktor,

Ryan McCabe,

Heidi Nelson,

Lawrence N. Shulman

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.3942

Subject(s) - medicine , cancer , interquartile range , colorectal cancer , lung cancer , logistic regression , cohort , retrospective cohort study , emergency medicine

Key Points Question Are there differences in survivorship between top-ranked cancer hospitals and affiliates that share a top-ranked hospital’s brand? Findings In this cohort study of 119 834 patients who underwent surgical treatment for esophageal, gastric, lung, pancreatic, colorectal, and bladder cancer, risk of 90-day mortality after complex cancer treatment was higher and long-term survival was inferior at affiliate hospitals. Meaning These findings suggest that quality improvement efforts are needed to address important differences in survival between top-ranked cancer hospitals and brand-sharing affiliate hospitals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research